| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/18/2002 | CA2429956A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/17/2002 | EP1221978A2 Technetium tc99m teboroxime myocardial perfusion agent |
| 07/17/2002 | EP1221974A2 Magnetic targeted carrier |
| 07/17/2002 | CN1087631C Radiolabeled peptides for diagnosis and therapy |
| 07/17/2002 | CN1087630C Radiolabeled compounds for thrombus imaging |
| 07/17/2002 | CN1087629C Brain perfuBion developer 99MTCN (CHDT)2 and its prepararing method |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | CA2068804C Electrolytic cell and process for the labeling of proteins and peptides |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053192A1 Stabilised radiopharmaceutical compositions |
| 07/11/2002 | WO2002053050A1 Method and apparatus for therapeutic emr treatment of the skin |
| 07/11/2002 | WO2002040507A3 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers |
| 07/11/2002 | WO2002032294A3 Radiopharmaceutical formulations |
| 07/11/2002 | WO2001083781A3 14094, a novel human trypsin family member and uses thereof |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | US20020090342 For use in therapy, medical diagnosis, as contrast agents in mangetic resonance imaging, x-rays and tompgraphy |
| 07/11/2002 | US20020090338 Radioactivity local delivery system |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | CA2433022A1 Method and apparatus for therapeutic emr treatment of the skin |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220691A1 Methods and apparatus for characterizing lesions in blood vessels and other body lumens |
| 07/10/2002 | EP1024838B1 Stable radioiodine conjugates and methods for their synthesis |
| 07/10/2002 | EP0820312B1 Ternary radiopharmaceutical complexes |
| 07/10/2002 | CN1087178C Isotopic urea tablets |
| 07/09/2002 | US6417384 Radioiodinated phospholipid ether analogs and methods of using the same |
| 07/09/2002 | US6417354 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 07/09/2002 | US6416738 Administering to a recipient a first conjugate comprising a targeting moiety and a member of a ligand/anti-ligand binding pair, thereafter administering to the recipient a clearing agent, administering second conjugate |
| 07/09/2002 | US6416735 Ligands for α-7 nicotinic acetylcholine receptors based on methyllcaconitine |
| 07/09/2002 | US6416733 Radiopharmaceuticals for imaging infection and inflammation |
| 07/04/2002 | WO2002052046A2 Oligonucleotide transfection screening method |
| 07/04/2002 | WO2002051448A1 Anti-tenascin monoclonal antibody therapy for lymphoma |
| 07/04/2002 | WO2002051447A1 Device for synthesis of radiopharmaceutical products |
| 07/04/2002 | WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001036007A3 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 07/03/2002 | EP1219307A2 Stable radioiodine conjugates and methods for their synthesis |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 07/03/2002 | EP1218351A2 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 07/03/2002 | EP0831941A4 Iodinated neuroprobes for mapping monoamine reuptake sites |
| 07/03/2002 | CN1356913A Vitronectic receptor antagonist pharmaceuticals |
| 07/02/2002 | US6414139 Silicon amphiphilic compounds and the use thereof |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413271 Method of making a radioactive stent |
| 07/02/2002 | CA2167678C Radioactive peptides |
| 07/02/2002 | CA2040204C Chelating compounds and their use |
| 07/02/2002 | CA2038493C 1,4,7,10-tetraazacyclododecane butyltriols |
| 07/02/2002 | CA2006372C Process for preparing isothiocyanato functionalized metal complexes |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | WO2002049644A1 Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders |
| 06/27/2002 | WO2002049501A2 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | WO2002026748A3 Metal complexes for use in medical and therapeutic applications |
| 06/27/2002 | WO2002024652B1 Compounds and methods for diagnosing and treating amyloid-related conditions |
| 06/27/2002 | WO2001092288A3 Cobalamin compounds useful as antibiotic agents and as imaging agents |
| 06/27/2002 | WO2001081426A3 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 06/27/2002 | WO2001074849A3 Binding peptides for carcinoembryonic antigen (cea) |
| 06/27/2002 | WO2001054680A3 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/27/2002 | WO2001041823A8 Radioactive compositions and methods of use thereof |
| 06/27/2002 | WO2001030393A8 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
| 06/27/2002 | US20020082398 For use in diagnosis and therapy |
| 06/27/2002 | US20020082389 Method and means for site directed therapy |
| 06/27/2002 | US20020081662 Radioiodinated sulfonated phenols and process therefore |
| 06/27/2002 | CA2432797A1 Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 06/27/2002 | CA2432066A1 Novel uses of non-peptide bombesin receptor antagonists for treating anxiety and panic disorders |
| 06/26/2002 | EP1216715A1 Synthesing device von radiopharmaceuticals |
| 06/26/2002 | EP1216056A1 Blocking immune response to a foreign antigen using an antagonist which binds to cd20 |
| 06/26/2002 | EP0896547B1 Diagnostic composition |
| 06/26/2002 | EP0752889B1 Liposomes containing a x-ray- or ultrasound contrast agent |
| 06/26/2002 | CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 06/25/2002 | US6410747 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
| 06/25/2002 | US6410695 Individual medicament dosing conjugate |
| 06/25/2002 | US6409990 Backbone comprising dextran having affixed thereto a plurality of groups having amino-alkyl-thio-alkyl-ether structure |
| 06/25/2002 | US6409988 Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands |
| 06/25/2002 | US6409987 Targeted agents useful for diagnostic and therapeutic applications |
| 06/25/2002 | US6409943 In-situ-generated solid radiation source based on Tungsten 188 /Rhenium 188 and use thereof |
| 06/20/2002 | WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 06/20/2002 | WO2002015943A3 Novel radiotherapeutic formulations containing 224ra and a method for their production |
| 06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 06/20/2002 | WO2001083436A3 Small technetium-99m and rhenium labeled agents and methods for imaging tumors |
| 06/20/2002 | WO2001054771A3 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 06/20/2002 | US20020077520 Device and method for dilating and irradiating a vascular segment or body passageway |
| 06/20/2002 | US20020077306 For imaging diagnosis and therapy |
| 06/20/2002 | US20020077280 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 06/20/2002 | US20020076406 Multivalent target binding protein |
| 06/19/2002 | EP1214946A2 Compositions and method for MRI-imaging malignant tumors using carbon 13 |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214312A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles |
| 06/19/2002 | EP1214100A2 Method for determining viability of a myocardial segment |
| 06/19/2002 | EP1214019A1 Radioactive graft or cuff |
| 06/19/2002 | CN1354882A Method of sterilizing radioactive seeds |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6406693 Killing tumor vascular endothelial cells by treatment with antibodies and binding with antigens |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2001002022A9 New melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma |
| 06/13/2002 | US20020071843 Targeted therapeutic agents |